Patents by Inventor Anita Boyapati

Anita Boyapati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240084041
    Abstract: The present disclosure provides methods for treating or inhibiting the growth of MET associated non-small cell lung cancer comprising selecting a subject with cancer and administering a therapeutically effective amount of a MET x MET bispecific antibody where each binding arm of the bispecific antibody interacts with a different MET epitope. In certain embodiments, the cancer harbors a MET alteration such as an exon 14 alteration in DNA or a deletion that leads to exon 14 skipping, a MET gene amplification, or MET protein overexpression.
    Type: Application
    Filed: August 31, 2023
    Publication date: March 14, 2024
    Inventors: Javier PEREZ, Petra RIETSCHEL, Mario Antonio NAVAS, Anita BOYAPATI
  • Publication number: 20230059376
    Abstract: Disclosed herein are methods for treating subjects having rheumatoid arthritis (RA) with a human anti-interleukin 6 (IL-6) antibody, or antigen-binding portion thereof.
    Type: Application
    Filed: March 23, 2022
    Publication date: February 23, 2023
    Inventors: Anita Boyapati, Neil Graham, Toshio Kimura, Jérôme Msihid
  • Patent number: 11319375
    Abstract: Disclosed herein are methods for treating subjects having rheumatoid arthritis (RA) with a human anti-interleukin 6 (IL-6) antibody, or antigen-binding portion thereof.
    Type: Grant
    Filed: August 28, 2019
    Date of Patent: May 3, 2022
    Assignees: Regeneron Pharmaceuticals, Inc., Sanofi Biotechnology
    Inventors: Anita Boyapati, Neil Graham, Toshio Kimura, Jérôme Msihid
  • Publication number: 20200405851
    Abstract: The present disclosure relates to the use of an anti-IL6 receptor antibody for treating rheumatoid arthritis in subjects with serum concentrations of certain biomarkers.
    Type: Application
    Filed: April 24, 2020
    Publication date: December 31, 2020
    Inventors: Anita Boyapati, Jérôme Msihid, Moshe E. Zilberstein
  • Publication number: 20200102395
    Abstract: Disclosed herein are methods for treating subjects having rheumatoid arthritis (RA) with a human anti-interleukin 6 (IL-6) antibody, or antigen-binding portion thereof.
    Type: Application
    Filed: August 28, 2019
    Publication date: April 2, 2020
    Inventors: Anita Boyapati, Neil Graham, Toshio Kimura, Jérôme Msihid